Breathe Well Live Well
|
Asthma may significantly raise heart attack risk
Economic Times "Physicians should do all they can to control every other modifiable cardiovascular risk factor in patients with asthma," said study author Matthew Tattersall, assistant professor at the University of Wisconsin-Madison School of Medicine and Public … |
View full post on asthma – Google News
Economic Times |
Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden
Economic Times MUMBAI: Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under … |
View full post on asthma – Google News
Economic Times |
Education and early medication can prevent Asthma attacks: Doctors
Economic Times As per a WHO report on World Asthma Day, the fundamental cause of asthma, that is characterised by recurrent attacks of breathlessness and wheezing is not completely understood, but the strongest risk factors for developing asthma include indoor … Poll campaign speeches lead to asthma attacks |
View full post on asthma – Google News
|
Economic Hardship Drives Hospital Readmissions For Asthma Treatment In …
News One African-American youth are twice as likely as Whites to be readmitted to the hospital for treatment of asthma, according to a new study by Cincinnati Children's Hospital, reports WCPO Cincinnati. SEE ALSO: 'Structural Racism' Blamed For Severe Health … |
View full post on asthma – Google News
 Economic Times |
Glenmark Generics recalls anti-asthma drug from US market
Economic Times HYDERABAD: Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on "off-odour" complaints, according to US Food and Drug Administration. |
View full post on asthma – Google News
 Economic Times |
India revokes patent for Merck asthma drug
Economic Times NEW DELHI: India has revoked a patent for an asthma drug held by US-based Merck following a challenge from local pharmaceutical giant Cipla, marking a new blow to global drug firms in the Indian market. The development is the latest in a string of … India revokes patent on Merck asthma drug Merck loses patent for asthma drug India Revokes Patent on Merck Asthma Drug -Reuters |
View full post on asthma – Google News
|
Dr Reddy's Laboratories launches generic anti-asthma drug in US market
Economic Times NEW DELHI: Drug maker Dr Reddy's Laboratories has launched its generic Montelukast Sodium oral granules used for treating asthma and seasonal allergies in the US market. The launch was made on September 26 following approval by the United States … |
View full post on asthma – Google News
 Zee News |
Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drug
Economic Times NEW DELHI: Drug firms Aurobindo Pharma and Glenmark today said they have received approval from the US health regulator to manufacture and market generic montelukast sodium tablets used for treating asthma and allergies. Both the companies said … Pharma cos set to gain from US nod for asthma drug |
View full post on asthma – Google News
|
Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA …
Economic Times NEW DELHI: Indian drug makers, including Aurobindo and Glenmark, are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. Last week the US Food and Drug … |
View full post on asthma – Google News
|
EPA disguises an economic disaster as a Christmas gift
Washington Examiner You talk about how 15 years ago your son spent his first Christmas in a hospital, suffering from asthma. Of course, you say nothing about the costs. Your state-by-state interactive map shows benefits for each state, but no costs. … Bishops join others in lauding new EPA toxins rule |
View full post on asthma – Google News